FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
AstraZeneca (NASDAQ: AZN) reported Q4 EPS of $1.45, $0.71 better than the analyst estimate of $0.74. Revenue for the quarter came in at $12.02 billion versus the consensus estimate of $12 billion.
GUIDANCE:
The Company issues its Total Revenue and Core EPS guidance for... More

